Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

FDA okays GSK's Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma's India facility

As the year draws to a close, the US Food and Drug Administration (FDA) appears busy approving drugs at a fast pace. This week...

Impressions : 898

Lilly to invest US$ 6 bn in new API plant in Alabama; Biocon buys remaining stake in Biocon Biologics, makes it 100% subsidiary

In this week’s Phispers, Eli Lilly announced yet another investment in the US — this time to build its largest API ...

Impressions : 784

Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs

In Phispers this week, Eli Lilly reduced prices of its obesity drug Zepbound sold through LillyDirect, aiming to expand access...

Impressions : 1049

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

In Phispers this week, Eli Lilly became the first pharmaceutical company to reach a market valuation of US$ 1 trillion, driven ...

Impressions : 1402

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA okays GSK's Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma's India facility

Lilly to invest US$ 6 bn in new API plant in Alabama; Biocon buys remaining stake in Biocon Biologics, makes it 100% subsidiary

Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

Hansoh's Generics Dapagliflozin Receives Tentative Approval in US

Novo Nordisk's Wegovy Receives Approval in US

RB Hlth's Mucinex Receives Approval in US

Amneal Pharms' Biologics Oziltus Receives Approval in US

Amneal Pharms' Biologics Boncresa Receives Approval in US

Boehringer Ingelheim Pharma's Jascayd Receives Approval in US

Cytokinetics' Myqorzo Receives Approval in US

Formyn AG's Biologics Nufymco Receives Approval in US

Creekwood Pharms' Generics Haloperidol Receives Approval in US

Teva' Generics Dapagliflozin Receives Tentative Approval in US

Gold Star Issues Recall of Certain FDA-Regulated Products

Maria A Carballosa's Receives FDA Warning Letter

Revive Rx dba Revive Rx Pharmacy's Receives FDA Warning Letter

Medinatura New Mexico's Receives FDA Warning Letter

Guangdong Renhe Guozhuang Biotech's Receives FDA Warning Letter

Handelnine Issues Nationwide Recall of Rheumacare Capsules

Enforcement Report - Week of December 17, 2025

Green Valley Fertility Partners' Receives FDA Warning Letter

Microvascular Tissue's Receives FDA Warning Letter

Sklar Personal Care's Receives FDA Warning Letter

Vanda Pharma Announces FDA Approval of NEREUS for Motion Sickness

Qiming Venture Partners' Insilico Medicine Lists On HKSE

Novo and Lilly Cut Prices of Weight-Loss Drugs in China

Genmab Scraps Development of Experimental Cancer Therapy

Ultragenyx Shares Plunge as Bone Disease Drug Fails

Trump Administration Agrees to Review Stalled NIH Research Grants

IMUNON Prices $7.0M Direct Offering Under NASDAQ Rules

Cannabix Secures First Order For Breathlogix Alcohol Screening

AIM Immunotech Announces Stock Dividend

Profound Medical Corp. Announces Closing Of Private Placement

Sun Pharma Eyes Obesity Drugs as Growth Driver

Intense Rivalry Between Lilly And Novo Opens Up India

Glenmark Pharma USA Launches Epinephrine Injection USP

Indian Pharma Hails FDA's BA/BE Safety Reporting Stance

Samsung Bioepis Launches Ustekinumab Biosimilar In Japan

Granules India Gets USFDA Tentative Approval For Amphetamine ER

FDA Approves Alembic's Travoprost Ophthalmic Solution USP

Senores Pharmaceuticals To Acquire Apnar Pharma And Five Andas

Cosette Pharma Launches Generic CIPRO HC With (CGT) Exclusivity

Amphastar Announces FDA Approval For Teriparatide Injection

Qiming Venture Partners' Insilico Medicine Lists On HKSE

Genmab Scraps Development of Experimental Cancer Therapy

Adaptive Bio To Present At 44th J.P. Morgan Healthcare Conference

Advanced Biomed Announces Disposal of its Hong Kong Subsidiary

Astal Signs Loi With Immuna Therapeutics

Cadrenal's Pipeline Shifts Towards Emergency Response System

Evogene Names Dr. Olga Nissan VP Of Business Development

Insilico Medicine Lists On Hkse, Leading AI Drug Discovery

Sinopia Biosciences Receives NIGMS Grant For Advancing LEADS

Sparkling Sciences Earns Dual U.S. Certifications

DoP Extends PLI Timeline for Bulk Drugs to Jan. 16, 2026

Symbiotec Pharmalab files DRHP with SEBI for IPO

CORONA Remedies Commissions Additional Capacity

Be Patient... Prices Of Your Medicines May Come Down Soon

Symbiosis Launches Manufacturing in New FDA-Inspected Facility

TAPI and Sagimet Biosciences Announce Global License Agreement

Global Recognition Prilocaine CEP Certified by EDQM

Bristol Myers Squibb Enhances U.S. Access To Vital Medicines

Protheragen Tackles FDA Drug Shortages with GLP-1 API Expansion

Inke Acquires Pharmanoid For Ophthalmic High Potent API Assets

Doctors Warn Against Antibiotic Misuse As Resistance Threat Grows

NPPA Permits Serum Institute To Halt Production Of 2 TT Vaccine

IIL Confirms Removal Of Counterfeit Abhayrab Rabies Vaccine

Drug Firms Extend GMP Compliance Time, States IDMA

Sun Pharma Arm Recalls 17K+ Antifungal Shampoos in US

Panel Urges Stringent Penalties For False Ayush Ads

CDSCO Reports 205 Samples As NSQ In November

TGA Seeks Feedback On Medicine Label Changes In Australia

Shape Memory Medical Obtains EU MDR Certification For IMPEDE

FDA Posts Warning Letters To Manufacturers Of Breast Binders

Breast Cancer Tops List Of Most-Studied Diseases In 2025

Desert Oasis Healthcare Raises Awareness About Mpox

KORU Medical Seeks 510(K) For Freedomedge System With Oncology